High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma.
about
Response to bevacizumab, irinotecan, and temozolomide in children with relapsed medulloblastoma: a multi-institutional experience.Irinotecan, vincristine, cisplatin, cyclophosphamide, and etoposide for refractory or relapsed medulloblastoma/PNET in pediatric patients.Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trial.Central nervous system cancersReirradiation of recurrent medulloblastoma: does clinical benefit outweigh risk for toxicity?Novel role of hematopoietic stem cells in immunologic rejection of malignant gliomas.Overcoming the challenges in the effective delivery of chemotherapies to CNS solid tumors.Global gene expression profiling confirms the molecular fidelity of primary tumor-based orthotopic xenograft mouse models of medulloblastoma.Molecular subgroups of adult medulloblastoma: a long-term single-institution studyPP2A inhibition with LB100 enhances cisplatin cytotoxicity and overcomes cisplatin resistance in medulloblastoma cells.Fourth generation phosphorus-containing dendrimers: prospective drug and gene delivery carrier.Evidence in medulloblastomas.Risk-adapted chemotherapy in childhood medulloblastoma.Management of recurrent medulloblastoma in adult patients: a systematic review and recommendations.High Incidence of Veno-Occlusive Disease With Myeloablative Chemotherapy Following Craniospinal Irradiation in Children With Newly Diagnosed High-Risk CNS Embryonal Tumors: A Report From the Children's Oncology Group (CCG-99702).Phase I study of temozolomide in combination with thiotepa and carboplatin with autologous hematopoietic cell rescue in patients with malignant brain tumors with minimal residual disease.Treatment of recurrent primitive neuroectodermal tumors (PNET) in children and adolescents with high-dose chemotherapy (HDC) and stem cell support: results of the HITREZ 97 multicentre trial.Medulloblastoma in an Adult With Late Extraneural Metastases to the Mediastinum.Decreased morbidity and mortality of autologous hematopoietic transplants for children with malignant central nervous system tumors: the 'Head Start' trials, 1991-2009.Marrow-ablative chemotherapy followed by tandem autologous hematopoietic cell transplantation in pediatric patients with malignant brain tumors.Immunotherapy for Pediatric Brain Tumors.A phase II study of radioimmunotherapy with intraventricular 131 I-3F8 for medulloblastoma.Tandem thiotepa with autologous hematopoietic cell rescue in patients with recurrent, refractory, or poor prognosis solid tumor malignancies.Relapse in medulloblastoma: what can be done after abandoning high-dose chemotherapy? A mono-institutional experience.Antiangiogenic metronomic therapy for children with recurrent embryonal brain tumors.Phase I study of tandem high-dose chemotherapy with autologous peripheral blood stem cell rescue for children with recurrent brain tumors: a Pediatric Blood and MarrowTransplant Consortium study.Author reply: To PMID 23279053.Reirradiation for recurrent medulloblastoma.Bevacizumab and irinotecan in the treatment of children with recurrent/refractory medulloblastoma.Metronomic antiangiogenic therapy in children with recurrent brain tumours of different histologies
P2860
Q33405154-4F09462E-50D1-4439-B842-21839B377301Q33408250-DDE06463-2894-4026-A5C1-992C021633B6Q33413067-CAD6C1F7-A0FF-4E3A-940A-6AE39EE4FED9Q34014740-F0B4829E-3FDF-4973-BF74-97CBD73D1BA4Q35192360-C53BFD0A-74DE-496F-9EF9-AB6232466445Q35507524-30F20355-65AF-4844-BD3E-4FC7D3B7D7FDQ35602796-C68E858F-661F-47EA-A4B1-803731611F77Q35914511-79B55B51-E13F-43F4-B9BA-3B2393B5FC1DQ36977713-75FCAD29-8324-4946-8427-9CBB10762824Q37022200-7E2898E3-132C-4947-B1D5-66D4E62D2C70Q37378143-1ACC198D-7F62-45D5-9C0B-0854A56310B5Q37750058-8121C725-33E8-4EF6-9BEF-AA66AB600D07Q37873471-147AA3B3-ADE8-491E-928A-51FDF2774523Q38123365-55E478CB-2957-4403-9D9A-6129FC5A7FC5Q40744398-CD49DD68-ED24-4975-BBAA-E9F0F90364BBQ41003114-5D23B3AB-BDE2-4A69-A054-75F119E15FA7Q41758419-91EE2077-C1E5-419A-881B-88368FE9E5DCQ41877184-930AE853-B72D-4978-AC81-E16924E8E669Q44603483-6B9AF823-7F3E-4D0B-9E44-EB064362D767Q45952870-DB860F8E-DEBC-4E20-871C-DCD7554B3817Q46407536-B4E9C848-2F97-48BE-8F77-12C0D5DD8D26Q47756231-11B40747-51C6-4809-B649-D95FA9BA8D10Q48113874-58FBE331-CCD0-40A3-9646-D6FDFEC82CAEQ48258994-C9C41A44-689C-49A7-B92F-AB02607E6B89Q48794915-8278261B-84FC-43D9-90D0-BA7DA129AFEEQ49065520-79A95B32-A8FC-4B90-84DE-CFEE2218D511Q55461185-3F8EA350-B0EA-4E35-AD5C-8B2A20EBADDCQ55463211-B1188F95-906B-4A40-802E-613FC6A2481FQ55463683-A9EEA4CF-B117-420A-9F45-D4AD94F4B0A5Q58034343-13D5887B-C9B2-477F-A7E9-E87A5B925A05
P2860
High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
High-dose carboplatin, thiotep ...... ted recurrent medulloblastoma.
@ast
High-dose carboplatin, thiotep ...... ted recurrent medulloblastoma.
@en
High-dose carboplatin, thiotep ...... ted recurrent medulloblastoma.
@nl
type
label
High-dose carboplatin, thiotep ...... ted recurrent medulloblastoma.
@ast
High-dose carboplatin, thiotep ...... ted recurrent medulloblastoma.
@en
High-dose carboplatin, thiotep ...... ted recurrent medulloblastoma.
@nl
prefLabel
High-dose carboplatin, thiotep ...... ted recurrent medulloblastoma.
@ast
High-dose carboplatin, thiotep ...... ted recurrent medulloblastoma.
@en
High-dose carboplatin, thiotep ...... ted recurrent medulloblastoma.
@nl
P2093
P2860
P356
P1433
P1476
High-dose carboplatin, thiotep ...... ated recurrent medulloblastoma
@en
P2093
James H Garvin
Jonathan L Finlay
Stewart Goldman
P2860
P304
P356
10.1093/NEUONC/NOP031
P577
2010-01-11T00:00:00Z